-
IR
2019/12/12
Annual Report 2019
-
IR
2019/11/18
Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31,2020
-
IR
2019/11/14
Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2020
-
IR
2019/11/05
Notification of the Borrowing of Funds
-
IR
2019/11/05
Notification of the Completion of the Acquisition of New Company Shares and Ownership of the Takatsuki Plant of Daiichi Sankyo Propharma Co., Ltd. (Subsidiary Acquisition)
-
IR
2019/08/20
Results Briefing Material for Financial Results fir the First Quarterof the Fiscal Year Ending March 31,2020
-
IR
2019/08/20
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31,2020
-
IR
2019/08/20
Annual Securities Report for the 73rd business term (April 1, 2018 to March 31, 2019)
-
IR
2019/06/14
Results Briefing Material for Financial Results for the Fiscal Year Ended March 31,2019
-
IR
2019/06/04
Notification of the Acquisition of a Long-listed Product
-
IR
2019/06/04
Consolidated Financia Results for the Fiscal Year Ended March 31,2019
-
IR
2019/05/30
NOTICE OF 73RD ORDINARY GENERAL SHAREHOLDERS’ MEETING
-
IR
2019/03/25
Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2019
-
IR
2019/03/25
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2019
-
IR
2019/03/25
Notice of Capital and Business Alliance with Cyfuse Biomedical K.K.
-
IR
2019/03/22
Notice of Investment with Wingo Technology Co.,Ltd.
-
IR
2019/02/14
Concerning acquisition of new company shares and ownership of Daiichi Sankyo Propharma Co., Ltd. Takatsuki Plant (subsidiary acquisition)
-
IR
2019/01/08
Completion of Transfer of Marketing and Manufacturing Rights of 13 Long-Term Listed Products from Chugai to Taiyo Pharma
